Signalling strength determines proapoptotic functions of STING

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Mammalian cells detect cytosolic nucleic acids via specific receptors.
• The cGAS-STING pathway is crucial for innate immunity, sensing cytosolic DNA and triggering cellular activation.
• The cell-type-specific outcomes of STING pathway activation are not well understood.

Purpose of the Study:

• To investigate whether the STING pathway's response varies across different mammalian cell types.
• To elucidate the specific effects of STING pathway activation in T cells.
• To explore the therapeutic potential of STING agonists in T-cell malignancies.

Main Methods:

• Comparative analysis of STING pathway activation in various mammalian cell types, focusing on T cells.
• Gene expression profiling to identify genes modulated by STING signaling in T cells.
• Assessment of apoptosis induction following STING pathway activation.
• In vivo studies using T-cell-derived tumors and STING agonists.

Main Results:

• T cells exhibit a significantly amplified STING response compared to other cell types.
• This intensified STING signaling in T cells leads to the expression of a unique gene set and induces apoptosis.
• The pro-apoptotic STING response remains functional in cancerous T cells.
• Administration of STING agonists suppressed the in vivo growth of T-cell tumors.

Conclusions:

• The magnitude of STING signaling dictates distinct cellular effector responses.
• STING pathway activation in T cells results in a pro-apoptotic outcome.
• Targeting the STING pathway with agonists presents a potential strategy for treating T-cell cancers.